China's Shanghai Pharmaceuticals R&D expenses 2015-2022
In 2022, Shanghai Pharmaceuticals Holding spent more than 2.8 billion yuan on research and development, accounting for about ten percent of the total business revenue. The enterprise has been increasing the amount of research and development expenses in the past years.